Condition: Migraine · Sponsor: AbbVie
The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| Flourish - Birmingham | Birmingham, Alabama, United States | Recruiting |
| Tennessee Valley Neurological Associates PC | Huntsville, Alabama, United States | Withdrawn |
| The Neurology Center of Southern California - Carlsbad Office | La Jolla, California, United States | Recruiting |
| Clinical Research Institute, LCC | Los Angeles, California, United States | Recruiting |
| Homestead Associates in Research, Inc. | Homestead, Florida, United States | Not Yet Recruiting |
| Florida Neurology - Lake Mary | Lake Mary, Florida, United States | Not Yet Recruiting |
| Flourish Research - Miami, LLC dba Flourish Research | Miami, Florida, United States | Recruiting |
| BayCare Medical Group Neurology at St. Anthony's Hospital | St. Petersburg, Florida, United States | Not Yet Recruiting |
| Santos Research Center, Corp - Tampa | Tampa, Florida, United States | Recruiting |
| Norton Neuroscience Institute - Headache Clinic | Louisville, Kentucky, United States | Withdrawn |
| Modern Migraine, MD | New York, New York, United States | Withdrawn |
| Velocity Clinical Research, Providence (East Greenwich) | East Greenwich, Rhode Island, United States | Not Yet Recruiting |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06602479